Keating Financial Advisory Services’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
Keating Financial Advisory Services's MIRM Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Mirum Pharmaceuticals (MIRM) stake by 60% in Q2 2026, buying an estimated $301 and bringing the position to 8 shares worth $937. The position accounts for ﹤0.01% of the portfolio, ranked #2189.
Keating Financial Advisory Services first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- Keating Financial Advisory Services held 8 shares of Mirum Pharmaceuticals worth $937 as of Q2 2026.
- Keating Financial Advisory Services bought 3 Mirum Pharmaceuticals shares in Q2 2026, an estimated $301.
- Mirum Pharmaceuticals made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2189 holding.
- Keating Financial Advisory Services first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.